Evaluation of the medical devices benchmark materials in the controlled human patch testing and in the RhE in vitro skin irritation protocol.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Evaluation of the medical devices benchmark materials in the controlled human patch testing and in the RhE in vitro skin irritation protocol.Published in
Toxicol in Vitro 2018; advance online publication (ahead of print)Publiekssamenvatting
Several irritants were used in the in vitro irritation medical device round robin. The objective of this study was to verify their irritation potential using the human patch test (HPT), an in vitro assay, and in vivo data. The irritants were lactic acid (LA), heptanoic acid (HA), sodium dodecyl sulfate (SDS), Genapol® X-80 (GP), and Y-4 polymer. Dilute saline and sesame seed oil (SSO) solutions of each were evaluated using a 4 and 18 h HPT and the EpiDerm™ SIT-MD RhE assay; results were then compared to existing rabbit skin irritation test data. Results from the 4 h HPT were negative in most cases except for GP and SDS, while the 18 h HPT also identified some LA, HA, and GP samples as irritants. EpiDerm™ SIT-MD correctly identified all irritants except GP in SSO due to limited solubility. Data from cutaneous rabbit irritation tests were negative, while all intracutaneous results were strongly or weakly positive except for the most dilute GP solutions. These findings indicate that EpiDerm™ SIT-MD results correlate with those from the rabbit intracutaneous test and confirm that RhE assays are suitable replacements for animals in evaluating the tissue irritation potential of medical devices.PMID
29462660ae974a485f413a2113503eed53cd6c53
10.1016/j.tiv.2018.02.009
Scopus Count
Collections
Related articles
- SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extracts.
- Authors: Pellevoisin C, Videau C, Briotet D, Grégoire C, Tornier C, Alonso A, Rigaudeau AS, Bouez C, Seyler N
- Issue date: 2018 Aug
- Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm™.
- Authors: Kandarova H, Willoughby JA, De Jong WH, Letasiova S, Milasova T, Bachelor MA, Breyfogle B, Handa Y, De la Fonteyne L, Coleman KP
- Issue date: 2018 Aug
- In vitro skin irritation testing: Improving the sensitivity of the EpiDerm skin irritation test protocol.
- Authors: Kandárová H, Hayden P, Klausner M, Kubilus J, Kearney P, Sheasgreen J
- Issue date: 2009 Dec
- In vitro human skin irritation test for evaluation of medical device extracts.
- Authors: Casas JW, Lewerenz GM, Rankin EA, Willoughby JA Sr, Blakeman LC, McKim JM Jr, Coleman KP
- Issue date: 2013 Dec
- Preparation of irritant polymer samples for an in vitro round robin study.
- Authors: Coleman KP, Grailer TP, McNamara LR, Rollins BL, Christiano NJ, Kandárová H, De Jong WH
- Issue date: 2018 Aug